ArticleRespiratory research2026
Unsupervised comprehensive CT imaging clusters reveal distinct morphological phenotypes in asthma: insights from two prospective cohorts.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundAsthma is a heterogeneous disease with diverse underlying structural abnormalities. Comprehensive evaluation of computed tomography (CT)-derived features may uncover novel morphological phenotypes with clinical relevance. This study aimed to identify and validate the morphological phenotypes of asthma using comprehensive inspiratory and expiratory CT features and assess their associations with clinical outcomes.
methodsWe analyzed two independent prospective asthma cohorts (Kyoto asthma cohort, n = 223; PACTAS study, n = 94) and a cross-sectional healthy control cohort (n = 88). Quantitative CT measures—airway morphology, mucus plugs, parenchyma, extrapulmonary structures, and pulmonary arteries—were quantified. Unsupervised clustering using these parameters was performed separately in each asthma cohort. Associations with lung function, type 2 inflammation, symptom burden, and exacerbations were examined.
resultsFour reproducible morphological phenotypes were identified. Cluster 1 (airway remodeling) was characterized by reduced airway lumen area (LA), and lower total airway count (TAC), along with higher mucus plug scores and elevated small airway dysfunction (SAD%) measured from inspiratory and expiratory lung density. Patients were older, had a longer asthma duration, and exhibited a lower forced expiratory volume in 1 s to forced vital capacity ratio (FEV₁/FVC). Cluster 2 (airway dilatation) showed enlarged LA, higher modified Reiff scores, and increased TAC. Patients tended to be younger, with a shorter disease duration and preserved lung function. Cluster 3 (metabolic abnormality) was characterized by reduced pectoralis muscle density and higher body mass index, and included predominantly female patients. This cluster was associated with a lower %FVC and greater symptom burden. Cluster 4 (parenchymal-dominant) consisted mainly of male smokers with emphysematous changes and higher SAD%, who exhibited lower FEV₁/FVC. Across both cohorts, Clusters 2–4 had exacerbation rates similar to or higher than in Cluster 1 in both unadjusted and adjusted analyses.
conclusionsComprehensive CT-based clustering revealed four reproducible morphological phenotypes of asthma—airway remodeling, airway dilatation, metabolic abnormality, and parenchymal-dominant—each associated with distinct structural and clinical features. These findings underscore the morphological heterogeneity of asthma and suggest that CT-based phenotyping may support more precise phenotype-specific treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.